Skip to main content
NCBI home page
Medical Journal of the Islamic Republic of Iran logoLink to Medical Journal of the Islamic Republic of Iran
. 2017 Mar 20;31:23. doi: 10.18869/mjiri.31.23

Pattern of some risk factors of cardiovascular diseases and liver enzymes among Iranian seafarers

Fereshteh Baygi 1, Olaf C Jensen 2, Mostafa Qorbani 3, Aliasghar Farshad 1, Seyed Ali Salehi 4, Fatemeh Mohammadi 5, Hamid Asayesh 6, Farzad Shidfar 7,*
PMCID: PMC5804442  PMID: 29445652

Abstract

Background: Little information is available on the trend in cardiovascular risk factors and hepatic enzymes in Iranian seafarers. The present study aimed at assessing the pattern of obesity, hypertension, diabetes, elevated serum glutamic oxaloacetate transaminase (SGOT), and serum glutamate pyruvate transaminase (SGPT) in Iranian seafarers during 2010 to 2014.

Methods: Data on cardiovascular risk factors and hepatic enzymes were extracted from seafarers’ annual health examination of National Iranian Tanker Company (NITC) of 2010, 2012, and 2014. The repeated measure ANOVA was used to compare continuous variables across 3 years. Categorical data were analyzed using Chi-square test. Over weight was defined as BMI (Body Mass Index) >25 kg/m2; obesity was defined as BMI>=30 kg/m2; hypertension was defined as systolic blood pressure (SBP)> 140 mmHg, and diastolic blood pressure (DBP)> 90 mmHg, or a history of antihypertensive drug use. Diabetes (DM) was defined as fasting blood sugar (FBS) > 110 mg/dl, or having a history of oral hypoglycemic agents; and elevated SGOT and SGPT were defined as SGOT > 40 U/L and SGPT > 40 U/L, respectively.

Results: The BMI mean±SD values of Iranian seafarers were 24.81±3.07 kg/m2, 25.51±2.96 kg/m2, and 25.96 ± 3.02 kg/m2 in 2010, 2012, and 2014, respectively. A significant difference was observed in BMI over the study period. The mean of systolic and diastolic blood pressure did not significantly increase over time. The SGOT and SGPT means were not significantly different from 2010 to 2014. The prevalence of overweight increased significantly from 46.7% to 60.9% over the study period; however, the prevalence of obesity, hypertension, elevated SGOT, and elevated SGPT did not change significantly.

Conclusion: The current survey showed that the obesity problem has increased among Iranian seafarers working on tankers, which is a concerning problem because obesity has negative effects on seafarers’ health.

Keywords: Seafarer, Cardiovascular, Prevalence, Liver Enzyme, Pattern

↑ What is “already known” in this topic:

The rate of diabetes and obesity is increasing exponentially.The prevalence of cardiovascular risk factors have increased during the recent years among the seafarers in various countries.

→ What this article adds:

The obesity has an increasing among Iranian seafarers working on tankers during 2010-2014.This is a main concern because obesity has negative effects on the health condition of the seafarers.

Introduction

Cardiovascular disease (CVD) is the main cause of death in the world (1), and its prevalence has increased in developing countries (2). Overweight, obesity, arterial hypertension, and hypercholesterolemia are some of the main risk factors causing the highest share of cardiovascular disease (3). Statistics show that death due to CVD is 33.7% in low-and middle-income countries (4). The increase in CVD morbidity and mortality in developing countries is associated with increased prevalence of cardiovascular risk factors (5). Several research have studied the prevalence of cardiovascular risk factors and their trends over time in normal population. Data show that about 180 million people have diabetes which will be doubled by the year 2030 in the developing world (6). The prevalence of obesity among adult population was 396 million in 2005, and it is estimated to reach 573 million by 2030 (7).

In 2008, a national study in Iran indicated that 7.7% of Iranian adults had diabetes, and 16.8% had impaired fasting glucose (8). Also, the estimated total number of Iranian obese males and females in 2005 was 42.8% and 57%, respectively (9). Based on the current studies on Iranian seafarers, the prevalence of MetS (Metabolic Syndrome) was 15%, and a large proportion of them had abdominal obesity (10). By 2015, these numbers are projected to be 54% and 74%, respectively (11). Previous studies revealed that the prevalence of hypertension among Iranian adults was 25.2% in 2005 (12); this figure reached to 26.6% in 2007 (13). Moreover, the majority of the patients with nonalcoholic fatty liver disease (NAFLD), who are obese, suffer abdominal obesity, Type 2 diabetes, and other cardiovascular risk factors (14). Results of the National Health and Nutrition Examination Survey (NHANES) revealed that about 70% of the elevated aminotransferase activity was significantly associated with higher body mass index, waist circumference, triglycerides, fasting insulin, and lower high density lipoprotein (HDL) cholesterol (15).

Seafaring is a crucial job in Iran, and the literature review shows that the prevalence of cardiovascular risk factors have increased during the recent years among the seafarers (16). Moreover, the prevalence of overweight, hypertension, and hypercholesterolemia increased during 1990s and 2000s among seafarers form various countries (16). Data revealed that the prevalence of obesity among Turkish seafarers has increased, and the highest level of BMI was observed among seafarers aged 50 to 60 years (17). Little is known about the trend in cardiovascular risk factors and hepatic enzymes in Iranian seafarers. Accordingly, the present study aimed at assessing the pattern of obesity, hypertension, diabetes, elevated SGOT, and SGPT in Iranian seafarers during 2010 to 2014.

Methods

Data

A retrospective cohort study was conducted, examining 500 Iranian male seafarers of NITC, who referred to health units for annual health examination to assess some patterns of risk factors of cardiovascular disease and liver enzymes. From 500 participants, 169 (33%) seafarers had at least 6 months of sea services and complete medical-demographic data in 2010, 2012, and 2014.

Data on cardiovascular risk factors and hepatic enzymes were derived from seafarers’ annual health examination of NITC of 2010, 2012, and 2014. The health examination data included age, height, weight, FBS, SGOT and SGPT, systolic, and diastolic blood pressure.

Measurement

Anthropometric parameters including height, weight, and blood pressure were measured according to standardized protocols. Weight was measured in light clothing without shoes using an electronic scale (Seca, 707; range 0.1-150 kg); height was measured without shoes using a tape meter, stadiometer. Body mass index (BMI) was calculated as weight (kg)/height2 (m2). Systolic and diastolic blood pressure were measured twice after 15 minutes rest and averaged in seated position, applying a standard mercury sphygmomanometer.

FBS (after 12-14 hours fasting), SGOT, and SGPT were tested using the relevant kits obtained from the Pars Azmoon Company, Iran, by an automatic analytical machine (BT3000, Italy).

Overweight was defined as BMI>25 kg/m2; obesity was defined as BMI>=30 kg/m2. High systole and high diastole were defined as systolic blood pressure (SBP)>140 mmHg and diastolic blood pressure (DBP)> 90 mmHg, respectively. Hypertension was defined as systolic blood pressure (SBP)> 140 mmHg and diastolic blood pressure (DBP)> 90 mmHg or a history of antihypertensive drug use (18). Diabetes was defined as fasting blood glucose > 110 mg/dL, or having a history of oral hypoglycemic agents (18). Elevated SGOT and SGPT were defined as SGOT > 40 U/L and SGPT > 40 U/L, respectively (19).

Ethical Considerations

This study was proposed and approved by the Ethics-in-Research Commission of Iran University of Medical Sciences. Also, permission was achieved from NITC to use Iranian seafarer information.

Statistical Analysis

The data were analyzed using SPSS16. Continuous variables were reported in mean and standard deviation (SD). The repeated measure ANOVA was used to compare continuous variables across 3 years. Categorical data were analyzed using Chi-square test. The significant level was set at p <0.05.

Results

The mean (SD) age of Iranian seafarers was 42.8 (10.4) years, and the mean (SD) job history was 16.7 (10.60) years. A total of 89 (52.7%) and 80 (47.3%) of the participants had diploma and academic degree, respectively; 77 (45.6%) did shift work.

Table 1 demonstrates the mean of BMI, FBS, SBP, DBP, and hepatic enzymes among participants in 3 intervals. The BMI mean of the participants significantly increased from 2010 to 2014 (p<0.001). In 2010, the mean (SD) values of SBP and DBP were 119.46 (13.22) mmHg and 75.94 (8.74) mmHg, respectively. In 2014, these mean values were 122.38 (14.41) mmHg and 78.89 (9.49) mmHg, respectively; however, this increase was not statistically significant (p= 0.062). Although the FBS mean decreased over the study period, it was not statistically significant (p= 0.22). The mean values of SGOT and SGPT did not change significantly among participants from 2010 to 2014.

Table 1. Mean±SD of the cardiovascular risk factors and hepatic enzymes on the participants from 2010 to 2014 .

Year, Mean ±SD
Risk Factors 2010 2012 2014 P-Trend
BMI 24.81±3.07 25.51±2.96 25.96±3.02 <0.001
Systolic blood pressure 119.46±13.22 119.14±15.10 122.38±14.41 NS
Diastolic blood pressure 75.94±8.74 74.95±9.99 78.89±9.49 NS
Fasting blood glucose 96.24±13.82 95.68±13.40 95.53±18.13 NS
SGOT 23.76±9.27 21.52±7.93 25.57±9.21 NS
SGPT 32.29±18.55 28.47±13.92 32.20±16.02 NS
Open in a new tab

The prevalence of cardiovascular risk factors and hepatic enzyme among Iranian seafarers are presented in Table 2. The prevalence of overweight increased significantly from 46.7% to 60.9% over the study period. Although the prevalence of obesity enhanced from 4.1% to 8.9%, it was not statistically significant. The rate of high SBP, high DBP, HTN, and diabetes increased from 2010 to 2014; however, the changes were not significant. The prevalence of elevated SGOT and SGPT were 6.5% and 25.4% in 2010, respectively; this prevalence was 5.9% and 21.3% in 2014, respectively, indicating no significant change between 2010 and 2014 prevalence values.

Table 2. Prevalence of cardiovascular risk factors and hepatic enzymes on the participants from 2010 to 2014 .

Year, Prevalence, %
Risk factors 2010 2012 2014 Relative Change From 2010 to 2014, % P value
Obesity 7 (4.1) 10 (5.9) 15 (8.9) 114 NS
Overweight 79 (46.7) 99 (58.6) 103 (60.9) 30.37 <0.01
High systole 16 (9.5) 20 (11.8) 25 (14.8) 56.25 NS
High diastole 20 (11.8) 35 (20.7) 24 (14.2) 20 NS
Hypertension 26 (15.4) 41 (24.3) 40 (23.7) 53.84 NS
Diabetes 37 (21.9) 33 (19.5) 49 (29.0) 32.43 NS
Elevated SGOT 11 (6.5) 4 (2.4) 10 (5.9) -9.09 NS
Elevated SGPT 43 (25.4) 25 (14.8) 36 (21.3) -16.27 NS
Overweight& Hypertension 21 (12.4) 26 (15.4) 30 (17.8) 42.85 NS
Overweight& Diabetes 23 (13.6) 16 (9.5) 28 (16.6) 21.73 NS
Hypertension& Diabetes 10 (5.9) 8 (4.7) 10 (5.9) 0 NS
Hypertension& Diabetes& Overweight 27 (16.9) 35 (21.3) 38 (23.9) 40.74 NS
Elevated SGOT& Elevated SGPT 10 (5.9) 4 (2.4) 7 (4.1) -30.0 NS
Open in a new tab

Figures 1-3 demonstrates the frequency of different combinations of cardiovascular risk factors from 2010 to 2014. The prevalence of having “HTN and obesity” did not change significantly over time, but the frequency of having “HTN and overweight” significantly increased from 12.4% to 17.8%. The frequency of combination of DM-overweight significantly increased from 2010 to 2014. Also, the prevalence of having diabetes-overweight-HTN among Iranian seafarers increased significantly from 5.3% to 5.9% between 2010 until 2014 (p<0.05).

Fig. 1.

Fig. 1

Frequency of Combination of HTN; a: Obesity, b: Overweight

Open in a new tab

Fig. 3.

Fig. 3

Frequency of combination of diabetes and HTN and overweight

Open in a new tab

Fig. 2.

Fig. 2

Frequency of combination of diabetes. a: Overweight, b: HTN

Open in a new tab

Discussion

The current study provides primary data on the increasing trend of overweight in Iranian seafarers’ population over the study period. The prevalence of hypertension, diabetes, elevated SGOT, and SGPT increased non-significantly from 2010 to 2014. Studies have found that the risk factors of non-communicable diseases’ trend have been increasing in both developing and developed countries (20-22). The prevalence of obesity among American adults increased from 13% to 32% between 1960s and 2004 (23,24). Similar increasing trend of diabetes is reported in adults’ population in the USA (25). The prevalence of obesity in Europe has doubled over the past 10 to 15 years (26). In developing countries, the increasing prevalence of diabetes is estimated to increase from 3.3% to 4.9% from 1995 to 2025 (27). A similar increase in obesity prevalence has been observed in developing countries (20); in Kuwait and Oman, the obesity prevalence rate has risen in recent years. The national prevalence of obesity in Kuwait increased from 15% to 28% from 1980 to 1994 (28), and in Oman, it increased from 10.5% to 16.7% from 1991 to 2000 (29). Recent studies have revealed that cardiovascular diseases risk factors have also increased in Iranian adults’ population (3,13,30,31). Data from the National Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD) showed that the prevalence of obesity increased from 13.6% in 1999 to 19.6% in 2005 and to 22.3% in 2007 among Iranian adults. During these years, the national prevalence of overweight was 32.2%, 35.8%, and 36.3%, respectively; ie, 4.1% increase in 8 years (3). According to SuRFNCD, the rate of diagnosed diabetes was 2.5%, 4.0%, and 4.6% in 1999, 2005, and 2007, respectively; ie, during 8 years, the prevalence of diabetes rose more than 1.8 fold among Iranian adults (31). In 2005, the national prevalence of hypertension was 25.2%; this number was 26.6% (1.4% increase in 2 years) in 2007 (13). Other studies presented alarming increases in the prevalence of overweight, obesity, and abdominal obesity in different regions of Iran (30,32,33). Possible reasons which can be accounted for increase in the prevalence of non-communicable diseases are improper dietary habits, inactivity, speedy urbanization, and imparity in health care (34).

The prevalence of cardiovascular risk factors are high among seafarers, which might be due to their different lifestyle (16). In the current study, the overweight trend increased significantly among seafarers by 14.2% from 2010 to 2014. The mean of BMI significantly increased among Iranian seafarers over time. The present findings are consistent with other studies (16,17,35). A review on the prevalence of cardiovascular risk factors among seafarers during 1990s and 2000s showed that the prevalence of overweight was 47.1% in 1990s and 64.1% in 2000s; and the prevalence of overweight increased significantly over time (16). Findings of Nas revealed that the mean of BMI among Turkish seafarers significantly raised from 2009 to 2012, and when the Turkish seafarers got older, their BMI values increased gradually (17). A survey was performed among Danish seafarers to find the trend of BMI from 2001/2002 to 2010, showing that the overweight prevalence was 64% in 2001/2002 and increased to 70.5% in 2010; and the relative risk of being overweight in 2010 was 1.08 compared to 2001/2002 (35). Published data show that the prevalence of high blood pressure significantly increased from 14.8% in 1990s to 42.1% in 2000s among seafarers (16), which is inconsistent with the present study. In our study, the mean of SBP and DBP did not increase significantly, and the trend of high systole, high diastole, and hypertension rose nonsignificantly among Iranian seafarers from 2010 to 2014. The findings revealed that the mean of fasting blood glucose did not change significantly over time, and the trend of diabetes did not increase significantly. The results are consistent with Pougnet et al.’s study (16), in which the prevalence of glycemic abnormalities or diabetes increased nonsignificantly from 3.9% to 4.0% during 1990s and 2000s. Documentaries show that factors such as inactivity, lack of sleeping, stress of work, unhealthy diet, and long job duration contribute to increase in cardiovascular risk factors among seafarers (36).

In our study, the mean of hepatic enzymes increased non-significantly from 2010 to 2014 among Iranian seafarers, hich might have been due to the short duration of the study or small sample size. Elevated level of SGPT is the main liver abnormality in NAFLD and nonalcoholic steatohepatitis (NASH). Statistics showed that the NAFLD prevalence was 25% among American adults (37). Previous studies have revealed significant associations between components of metabolic syndrome and NAFLD and NASH (38). The prevalence of elevated SGPT among Iranian population is 4.3%, suggesting that the rate of NAFLD/NASH and related complications are expected to rise among Iranian population in the future (39). Recent evidences indicate that NAFLD is the main common reason of liver disease in Iran (40).

The main strength of the study was that it was the first study to report the pattern of cardiovascular risk factors and liver enzymes among Iranian seafarers working on tankers. The study had a number of limitations: Nutritional habits and physical activity were not considered simultaneously in the study, moreover, the study was conducted in a short-term; and in this regard small sample size might have been the main reason for non-significant results of the current survey. Thus, the results may not be appropriately generalized.

Conclusions

The current survey showed that the obesity problem has increased among Iranian seafarers working on tankers in the recent years, which is a main concern because obesity has negative effects on the health condition of the seafarers. Longitudinal studies on seafarers are needed to investigate the trend of cardiovascular risk factors and other risk factors of this occupation.

Acknowledgments

The study data were derived from the PhD thesis of Ms. Fereshteh Baygi, a student of the Occupational Health Research Center of Iran University of Medical Sciences. The authors gratefully acknowledge the financial support of Iran University of Medical Sciences (Grant No. 25800). The authors would like to thank the manager and participants of National Iranian Tanker Company for their contribution.

Conflict of Interests:

The authors declare no competing interests.

Cite this article as: Baygi F, Jensen OC, Qorbani M, Farshad AA, Salehi SA, Mohammadi F, Asayesh H, Shidfar F*. Pattern of some risk factors of cardiovascular diseases and liver enzymes among Iranian seafarers. Med J Islam Repub Iran. 2017 (20 Mar); 31:23. https://doi.org/10.18869/mjiri.31.23

References

  • 1.Fuster V, Voute J. MDGs: chronic diseases are not on the agenda. Lancet. 2005;366(9496):1512–4. doi: 10.1016/S0140-6736(05)67610-6. [DOI] [PubMed] [Google Scholar]
  • 2.Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005;112(23):3547–53. doi: 10.1161/CIRCULATIONAHA.105.591792. [DOI] [PubMed] [Google Scholar]
  • 3.Esteghamati A, Khalilzadeh O, Mohammad K, Meysamie A, Rashidi A, Kamgar M. et al. Secular trends of obesity in Iran between 1999 and 2007: National Surveys of Risk Factors of Non-communicable Diseases. Metabolic syndrome and related disorders. 2010;8(3):209–13. doi: 10.1089/met.2009.0064. [DOI] [PubMed] [Google Scholar]
  • 4.Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low-and middle-income countries. Current problems in cardiology. 2010;35(2):72–115. doi: 10.1016/j.cpcardiol.2009.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Reddy KS. Cardiovascular disease in non-Western countries. New England Journal of Medicine. 2004:2438–510. doi: 10.1056/NEJMp048024. [DOI] [PubMed] [Google Scholar]
  • 6.Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world—a growing challenge. New England Journal of Medicine. 2007;356(3):213–5. doi: 10.1056/NEJMp068177. [DOI] [PubMed] [Google Scholar]
  • 7.Kelly T, Yang W, Chen C-S, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. International journal of obesity. 2008;32(9):1431–7. doi: 10.1038/ijo.2008.102. [DOI] [PubMed] [Google Scholar]
  • 8.Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F. et al. Prevalence of Diabetes and Impaired Fasting Glucose in the Adult Population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care. 2008;31(1):96–8. doi: 10.2337/dc07-0959. [DOI] [PubMed] [Google Scholar]
  • 9.Janghorbani M, Amini M, Willett WC, Gouya MM, Delavari A, Alikhani S. et al. First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults. Obesity. 2007;15(11):2797–808. doi: 10.1038/oby.2007.332. [DOI] [PubMed] [Google Scholar]
  • 10.Baygi F, Jensen O, Qorbani M, Farshad A, Salehi S, Mohammadi F. et al. Prevalence and Associated Factors of Cardio-Metabolic Risk Factors in Iranian Seafarers. Int Marit Health. 2016;67(2):59–65. doi: 10.5603/IMH.2016.0013. [DOI] [PubMed] [Google Scholar]
  • 11. Chronic deaseases are the major cause of death and disability worldwide: World Health Organization; [updated Cited 2008 Aug 12]. Available from: [http://www.who.int/chp/chronic_disease_report/media/Factsheet1.pdf].
  • 12.Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, Shishehbor MH. et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens. 2008;21(6):620–6. doi: 10.1038/ajh.2008.154. [DOI] [PubMed] [Google Scholar]
  • 13.Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F. et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC public health. 2009;9(1):167. doi: 10.1186/1471-2458-9-167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis. 2007;191(2):235–40. doi: 10.1016/j.atherosclerosis.2006.08.021. [DOI] [PubMed] [Google Scholar]
  • 15.Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of non‐alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes/metabolism research and reviews. 2006;22(6):437–43. doi: 10.1002/dmrr.666. [DOI] [PubMed] [Google Scholar]
  • 16.Pougnet R, Pougnet L, Loddé BL, Canals-Pol ML, Jegaden D, Lucas D. et al. Cardiovascular risk factors in seamen and fishermen: review of literature. International maritime health. 2013;64(3):107–13. [PubMed] [Google Scholar]
  • 17.Nas S, Fışkın R. A research on obesity among Turkish seafarers. International maritime health. 2014;65(4):187–91. doi: 10.5603/IMH.2014.0036. [DOI] [PubMed] [Google Scholar]
  • 18.S A, H K, MR M, B L, MH F, H A. Cut-off points of waist circumference and body mass index for detecting diabetes, hypercholesterolemia and hypertension according to National Non-Communicable Disease Risk Factors Surveillance in Iran. Arch Med Sci. 2011;8(4):614–21. doi: 10.5114/aoms.2012.30284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rogha M, Najafi N, Azari A, Kaji M, Pourmoghaddas Z, Rajabi F. et al. Non-alcoholic Steatohepatitis in a Sample of Iranian Adult Population: Age is a Risk Factor. Int J Prev Med. 2011;2(1):24–7. [PMC free article] [PubMed] [Google Scholar]
  • 20.Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ. et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9· 1 million participants. The Lancet. 2011;377(9765):557–67. doi: 10.1016/S0140-6736(10)62037-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. The Lancet. 2005;365(9455):217–23. doi: 10.1016/S0140-6736(05)17741-1. [DOI] [PubMed] [Google Scholar]
  • 22.Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ. et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2· 7 million participants. The Lancet. 2011;378(9785):31–40. doi: 10.1016/S0140-6736(11)60679-X. [DOI] [PubMed] [Google Scholar]
  • 23.Wang Y, Beydoun MA. The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiologic reviews. 2007;29(1):6–28. doi: 10.1093/epirev/mxm007. [DOI] [PubMed] [Google Scholar]
  • 24.Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007;132(6):2087–102. doi: 10.1053/j.gastro.2007.03.052. [DOI] [PubMed] [Google Scholar]
  • 25.Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C. et al. Full accounting of diabetes and pre-diabetes in the US population in 1988–1994 and 2005–2006. Diabetes Care. 2009;32(2):287–94. doi: 10.2337/dc08-1296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Berghöfer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN. Obesity prevalence from a European perspective: a systematic review. BMC public health. 2008;8(1):200. doi: 10.1186/1471-2458-8-200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414–31. doi: 10.2337/diacare.21.9.1414. [DOI] [PubMed] [Google Scholar]
  • 28.Al-Isa A. Changes in body mass index (BMI) and prevalence of obesity among Kuwaitis 1980-1994. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity. 1997;21(12):1093–9. doi: 10.1038/sj.ijo.0800505. [DOI] [PubMed] [Google Scholar]
  • 29.Al-Lawati JA, Jousilahti PJ. Prevalence and 10-year secular trend of obesity in Oman. Saudi medical journal. 2004;25(3):346–51. [PubMed] [Google Scholar]
  • 30.Azizi F, Azadbakht L, Mirmiran P. Trends in overweight, obesity and central fat accumulation among Tehranian adults between 1998–1999 and 2001–2002: Tehran lipid and glucose study. Annals of nutrition and metabolism. 2005;49(1):3–8. doi: 10.1159/000084171. [DOI] [PubMed] [Google Scholar]
  • 31.Esteghamati A, Ashraf H, Khalilzadeh O, Rshidi A, Mohammad K, Asgari F. et al. Trends of diabetes according to body mass index levels in Iran: results of the national Surveys of Risk Factors of Non‐Communicable Diseases (1999–2007) Diabetic Medicine. 2010;27(11):1233–40. doi: 10.1111/j.1464-5491.2010.03103.x. [DOI] [PubMed] [Google Scholar]
  • 32.Hosseinpanah F, Barzin M, Eskandary PS, Mirmiran P, Azizi F. Trends of obesity and abdominal obesity in Tehranian adults: a cohort study. BMC public health. 2009;9(1):426. doi: 10.1186/1471-2458-9-426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Veghari G, Sedaghat M, Maghsodlo S, Banihashem S, Moharloei P, Angizeh A, et al. Obesity trends of adults in northern Iran (2006-2010). 2013.
  • 34.Galal O. Nutrition-related health patterns in the Middle East. Asia Pacific journal of clinical nutrition. 2002;12(3):337–43. [PubMed] [Google Scholar]
  • 35.Hansen HL, Hjarnø L, Jepsen JR. Obesity continues to be a major health risk for Danish seafarers and fishermen. International maritime health. 2011;62(2):98. [PubMed] [Google Scholar]
  • 36.Oldenburg M. Risk of cardiovascular diseases in seafarers. International maritime health. 2014;65(2):53–7. doi: 10.5603/IMH.2014.0012. [DOI] [PubMed] [Google Scholar]
  • 37.Green RM. NASH—hepatic metabolism and not simply the metabolic syndrome. Hepatology. 2003;38(1):14–7. doi: 10.1053/jhep.2003.50325. [DOI] [PubMed] [Google Scholar]
  • 38.Donati G, Stagni B, Piscaglia F, Venturoli N, Morselli-Labate A, Rasciti L. et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut. 2004;53(7):1020–3. doi: 10.1136/gut.2003.027086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Sohrabpour AA, Rezvan H, Amini-Kafiabad S, Dayhim MR, Merat S, Pourshams A. Prevalence of Nonalcoholic Steatohepatitis in Iran: A Population based Study. Middle East Journal of Digestive Diseases. 2010;2(1):14–9. [PMC free article] [PubMed] [Google Scholar]
  • 40.Jamali R, Khonsari M, Merat S, Khoshnia M, Jafari E, Bahram Kalhori A. et al. Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol. 2008;14(18):2867–71. doi: 10.3748/wjg.14.2867. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medical Journal of the Islamic Republic of Iran are provided here courtesy of Iran University of Medical Sciences

RESOURCES